BPM Mezzanine Fund II provided financing to Averton Sterling for the acquisition of Medical Mazella
BPM Mezzanine Fund II usaldusfond has provided financing for an MBI transaction in the rigid polymer packaging sector - an acquisition of Medical Mazella Sp. z o.o. – a Polish producer of specialized packaging solutions by the MBI Team led by dr Jakub Niestrój. Medical Mazella sp. z o.o is a leading manufacturer of PP/PET/PE rigid packaging for the pharmaceutical, laboratory, and e-fluid segments. The Company has a long history of growth and strong profitability and the new management team will embark on a scaling up path. This strategic financing supports Medical Mazella's expansion in the medical sector, reinforcing the Company’s market presence and growth potential.
Commenting on the deal, Jakub Niestrój, the CEO of Medical Mazella noted: “The buy-out of Medical Mazella is the first step in implementing an expansion strategy in the specialist packaging sector. We look forward to cooperating with the Company’s existing clients and vastly increasing the business and its client and product portfolio in the future. I believe that consolidation in this market is inevitable and we are in a good position to participate in this process forward.”
For the BPM team, it marked the next transaction from its second fund – BPM Mezzanine Fund II usaldusfond, which continues the mezzanine strategy of the first fund.
Paweł Zabrzycki, Partner of BPM, said: “We are very happy to be able to back an ambitious management team in this exciting expansion project. It is an outstanding opportunity to invest in a specialist packaging business with a prominent customer base and a great product quality reputation. We share the view of the management team that there is definitely room for consolidation in this sector in Poland and are very excited to back them in this process.”